We recently compiled a list of the Why These 15 Stocks Are Skyrocketing in 2025. In this article, we are going to take a look ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Demant (WILLF – Research Report) and ...

Fintel reports that on January 23, 2025, Barclays initiated coverage of Guardant Health (NasdaqGS:GH) with a Overweight ...

Leerink Partners analyst Puneet Souda has maintained their bullish stance on GH stock, giving a Buy rating yesterday.Invest with Confidence: ...

Guardant Health Inc (GH) stock saw a decline, ending the day at $47.21 which represents a decrease of $-1.39 or -2.86% from the prior close of $48.6. The stock opened at $48.26 and touched a low of ...

Guardant Health, Inc. (NASDAQ:GH) announced that Palmetto GBA, a Medicare administrative contractor that administers the ...

Investment analysts at Leerink Partnrs lifted their Q4 2024 earnings per share estimates for Guardant Health in a research report issued on Tuesday, January 21st. Leerink Partnrs analyst P. Souda now ...

In terms of valuation, Guardant Health Inc’s market capitalization stands at $6.00 billion. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market ...

Despite Guardant Health's positive Q4 2024 report, it remains unprofitable with negative cash flow, unlike its peer Natera.

Guardant Health has not completed preparation of its financial statements for the fourth quarter or full year of 2024. The ...

Guardant Health has reported preliminary full-year 2024 revenues of $737m, reflecting year-over-year (YOY) growth of 31%, ...

In an early look at its annual earnings report, Guardant Health posted revenue gains of 31%—with the $737 million total ...